AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimymed M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Msb Pharma Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimymed M 2mg/500mg Tablet ER

Diabex Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including a balanced diet, regular physical activity, and weight management as directed by your doctor. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify its symptoms – sweating, lightheadedness, headache, tremor – and implement appropriate countermeasures. Maintain regular mealtimes and carry readily available glucose sources like sweets or juice. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment; suitability may be affected. Pregnant or lactating individuals must consult their physician prior to use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimymed M 2mg/500mg Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Glimymed M 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimymed M 2mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimymed M 2mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Glimymed M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimymed M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimymed M 2mg/500mg Extended-Release tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.

How Glimymed M 2mg/500mg Tablet ER works:

Glimymed M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimymed M 2mg/500mg ER tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimymed M 2mg/500mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimymed M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimymed M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician. Glimymed M 2mg/500mg Extended-Release tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimymed M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. In individuals with mild to moderate hepatic dysfunction, initiation with a low dose is typical; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimymed M 2mg/500mg Tablet ER :

Should you forget a Glimymed M 2mg/500mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimymed M 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes medication

FAQs on Glimymed M 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep out of reach of children, pets, and others.
Glimymed M 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimymed M 2mg/500mg Tablet ER and seek immediate medical attention.
Glimymed M 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimymed M 2mg/500mg ER tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimymed M 2mg/500mg Tablet ER can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental Vitamin B12 intake is recommended annually by some researchers.
Glimymed M 2mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimymed M 2mg/500mg ER tablets with alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimymed M 2mg/500mg Tabl...
60
MRP 70
14% off